Captopril 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±2.2 mmHg at 25℃ |
| Water Solubility | Soluble |
| Assay Purity | >98%(HPLC) |
| B pt. | 427℃ at 760 mmHg |
| M pt. | 106℃ |
| Density | 1.272 g/cm3 |
Safety Information
| Hazard Statement(s) | H341 - H360F |
| Precautionary Statement | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Symbol |
|
| Signal word | Danger |
| HS Code | 2933990090 |
| Flash point | 212.1℃ |
| Storage Temp. | Store at room temperature |
| Packaging | Glass Bottle |
Description
Recommended products
(S)-(-)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
Application
Captopril has been used as an angiotensin-converting enzyme inhibitor and orally administered to unrestrained Wistar Kyoto rats in an approach to study its effects of angiogenesis inhibition and interdependency with other drugs used as a positive control in spectrophotometric assay to study the angiotensin-converting enzyme inhibitory activity to examine the influence of timing of captopril treatment on efficacy in transverse aortic constriction (TAC) mice
Purpose
For R&D use onlynot for drug household or other uses.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |